Bronchodilatory effects of ipratropium bromide in patients with tetraplegia

P. L. Almenoff, L. R. Alexander, A. M. Spungen, M. D. Lesser, W. A. Bauman

Research output: Contribution to journalArticlepeer-review

41 Scopus citations

Abstract

Airway hyperresponsiveness was recently described in patients with chronic cervical spinal cord injury (tetraplegia). The response was attributed to unopposed cholinergic broncho- constrictor activity due to loss of sympathetic innervation of the airway. To determine if the administration of a cholinergic antagonist alters resting airway tone in these patients, ipratropium bromide (72 f.ig) was administered by aerosol to 25 tetraplegic patients. We found that 12 of 25 patients (48%) had significant improvement (defined as ≥12%) in forced expired volume in 1 s (FEV)) and/or forced vital capacity (FVC). A significant correlation between airway responsiveness and complaints of dyspnea at rest, completeness of injury (sensory), or smoking history was not found. These findings of improved airflow after the use of an anticholinergic bronchodilator agent provides further evidence that transection of the cervical cord results in unopposed parasympathetic activity and a resultant increase in resting airway tone.

Original languageEnglish
Pages (from-to)274-277
Number of pages4
JournalParaplegia
Volume33
Issue number5
DOIs
StatePublished - May 1995

Keywords

  • Anti-cholinergic agents
  • Bronchial obstruction
  • Ipratropium
  • Lungs
  • Pulmonary
  • Spinal cord injury
  • Tetraplegia

Fingerprint

Dive into the research topics of 'Bronchodilatory effects of ipratropium bromide in patients with tetraplegia'. Together they form a unique fingerprint.

Cite this